PTX 0.00% 4.0¢ prescient therapeutics limited

Ann: June 2018 Appendix 4C - Quarterly, page-28

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,075 Posts.
    lightbulb Created with Sketch. 43
    One man’s poison is another’s meat...,
    Welcome to biotech’s.
    Have held and sold many over just as many years. Some gains, some losses yet all share the same pattern of vulnerability..., including some blue chip.
    Have bought ptx as low as 5 or so cents and as high as 13.5 cents over last 3-4 years without the sale of even one share.
    Professional management, internationally recognised scientific team and although still experimental (early to mid phase of trials) promising compounds with a vision for precision medicine aim.
    Today’s sp ‘failure’ may or may not be someone’s bargain entry or further accumulation..., who knows.
    The lack of gap between 9 to 5 cents today listed may not be the case if the SP continues to decline.
    A 15% decline on less than 700 k of shares suggests to me a seller (s) between projects willing to make a loss in order to further invest in others..., maybe not.
    Until a negative announcement is made public, happy to hold and accumulate on this one.
    Please do your own research and the above is simply my opinion and not financial advice.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $22.35K 558.4K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 860576 3
View Market Depth
Last trade - 14.51pm 19/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.